Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
25.20
+1.10 (4.56%)
At close: Aug 13, 2025, 4:00 PM
25.29
+0.09 (0.36%)
After-hours: Aug 13, 2025, 6:44 PM EDT
Liquidia Revenue
Liquidia had revenue of $8.84M in the quarter ending June 30, 2025, with 141.51% growth. This brings the company's revenue in the last twelve months to $19.32M, up 30.20% year-over-year. In the year 2024, Liquidia had annual revenue of $14.00M, down -19.97%.
Revenue (ttm)
$19.32M
Revenue Growth
+30.20%
P/S Ratio
104.07
Revenue / Employee
$113,659
Employees
170
Market Cap
2.15B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
LQDA News
- 4 hours ago - Liquidia Analysts Raise Their Forecasts Following Q2 Results - Benzinga
- 1 day ago - Why Is Liquidia Stock Trading Higher On Tuesday? - Benzinga
- 1 day ago - Liquidia Corporation (LQDA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - What Next For Liquidia After Launch? - Seeking Alpha
- 7 weeks ago - Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™ - GlobeNewsWire
- 2 months ago - Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD - GlobeNewsWire
- 2 months ago - These Analysts Boost Their Forecasts On Liquidia - Benzinga